Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), issued the following statement regarding an article published by The Marker :
“The company is aware of an article published this morning by The Marker in Israel that claims to feature a copy of Teva’s long range financial planning forecast for the years 2013 through 2018.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
This information, which appears to be from an outdated presentation is incomplete and does not reflect our full analysis, and was provided to The Marker without Teva’s authorization. The company is extremely disappointed that confidential, potentially misleading and obsolete information was made public at this time and intends to investigate the unauthorized dissemination and publication.
The company is in the process of completing its annual planning and expects to provide its full-year 2014 financial outlook in December and does not intend to comment further until then.